These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3480081)

  • 41. Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.
    Kreis W; Rottach C; Budman DR; Chan K; Schulman P; Allen SL; Weiselberg L; Vinciguerra V
    Cancer Res; 1988 Oct; 48(19):5580-4. PubMed ID: 3166400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia.
    Avramis VI; Biener R; Krailo M; Finklestein J; Ettinger L; Willoughby M; Siegel SE; Holcenberg JS
    Cancer Res; 1987 Dec; 47(24 Pt 1):6786-92. PubMed ID: 3479250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
    Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
    Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
    Lee EJ; Reck K; Carter C; Hodges S; Schiffer CA
    Leukemia; 1993 Oct; 7(10):1500-3. PubMed ID: 8412310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three dose regimens of adriamycin for induction of remission in acute leukemia in children: a Southwest Oncology Group Study.
    Starling KA; Berry DH; Britton HA; Humphrey GB; Vats T; Ragab AH
    Med Pediatr Oncol; 1975; 1(3):271-6. PubMed ID: 1232534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
    Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic effects of a combination of intermediate-dose cytosine arabinoside, adriamycin and vincristine in relapsed acute leukemia].
    Takahashi I; Yorimitsu S; Inagaki T; Sekito N; Hayashi N; Nishimura M; Aoyama S; Nakada H; Ohmoto E; Uchida K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):485-9. PubMed ID: 3813576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting glycometabolic reprogramming to restore the sensitivity of leukemia drug-resistant K562/ADM cells to adriamycin.
    Zhang X; Chen J; Ai Z; Zhang Z; Lin L; Wei H
    Life Sci; 2018 Dec; 215():1-10. PubMed ID: 30473023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia.
    Lockhart S; Plunkett W; Jeha S; Ramirez I; Zipf T; Cork A; Pinkel D
    J Clin Oncol; 1994 Mar; 12(3):587-95. PubMed ID: 8120558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer.
    Twelves CJ; Dobbs NA; Aldhous M; Harper PG; Rubens RD; Richards MA
    Cancer Chemother Pharmacol; 1991; 28(4):302-7. PubMed ID: 1879047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats.
    Ueda Y; Munechika K; Kikukawa A; Kanoh Y; Yamanouchi K; Yokoyama K
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1639-41. PubMed ID: 2476250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake of adriamycin by sarcoma transplants in the rat kidney: effects of renal arterial vs systemic constant rate infusion and of combination with ricin.
    Tvete ST; Elsayed EA; Hope A; Clausen G
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):127-34. PubMed ID: 6682770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia.
    DeGregorio MW; Carrera CJ; Klock JC; Pegelow CH; Wilbur JR
    Cancer Treat Rep; 1982 Dec; 66(12):2085-8. PubMed ID: 6958366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H; Takahashi H; Miyamoto K; Uchida T; Tokiwa T
    Cancer Chemother Pharmacol; 1996; 38(5):417-24. PubMed ID: 8765434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation.
    Fasola G; Lo Greco P; Calori E; Zilli M; Verlicchi F; Motta MR; Ricci P; Baccarani M; Tura S
    Haematologica; 1991; 76(2):120-5. PubMed ID: 1937169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I study of a continuous infusion of high-dose ara-C in conjunction with a fixed dose of 2'-deoxycytidine (IND 28108) in patients with refractory leukemia: an interim report.
    Grant S; Baker M; Bhalla K
    Leukemia; 1993 Dec; 7(12):1933-8. PubMed ID: 8255091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular pharmacokinetics of 2-chloro-2'-deoxyadenosine nucleotides: comparison of intermittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients.
    Liliemark J; Juliusson G
    Clin Cancer Res; 1995 Apr; 1(4):385-90. PubMed ID: 9815995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.